Tags

Type your tag names separated by a space and hit enter

D2-like receptor agonist synergizes the μ-opioid agonist spinal antinociception in nociceptive, inflammatory and neuropathic models of pain in the rat.
Eur J Pharmacol. 2019 Jun 15; 853:56-64.EJ

Abstract

Opioids are potent analgesic drugs, but their use has been limited due to their side effects. Antinociceptive effects of D2-like receptor agonists such as quinpirole have been shown at the spinal cord level; however, their efficacy is not as high as that of opioids. Dopaminergic agonists are long-prescribed and well-tolerated drugs that have been useful to treat clinically and experimentally painful conditions. Because current pain treatments are not completely effective, the aim of this work was to determine if a D2-like receptor agonist improves the antinociceptive effects of a μ-opioid receptor agonist. Drugs were intrathecally administered in adult rats; mechanonociceptive and thermonociceptive tests were carried out. Intraplantar injection of complete Freund's adjuvant (CFA) and sciatic loose ligation (SLL) were used for inflammatory and neuropathic models of pain, respectively. In intact animals, D-Ala2, N-MePhe4, Gly-ol-enkephalin (DAMGO; a µ-opioid receptor agonist) increased the paw withdrawal latencies (PWL) in thermal and mechanical nociceptive tests in a dose-dependent manner. Quinpirole (D2-like receptor agonist) increased PWL only in mechanonociception. In the presence of quinpirole (1 nmol), the ED50 of the mechanical antinociceptive effect of DAMGO was significantly decreased (8-fold). Coadministration of 1 nmol quinpirole and 30 pmol DAMGO completely reversed hyperalgesia in the CFA model, whereas 100 pmol DAMGO plus 1 nmol quinpirole reversed the allodynia in the SLL model. This work offers evidence about a synergistic antinociceptive effect between opioidergic and dopaminergic drugs. This combination may relieve painful conditions resistant to conventional treatments, and it may reduce the adverse effects of chronic opioid administration.

Authors+Show Affiliations

Laboratorio de Fisiología Celular, Dirección de Investigaciones en Neurociencias. Instituto Nacional de Psiquiatría Ramón de la Fuente Muñiz, Ciudad de México, Mexico.Laboratorio de Fisiología Celular, Dirección de Investigaciones en Neurociencias. Instituto Nacional de Psiquiatría Ramón de la Fuente Muñiz, Ciudad de México, Mexico.Laboratorio de Fisiología Celular, Dirección de Investigaciones en Neurociencias. Instituto Nacional de Psiquiatría Ramón de la Fuente Muñiz, Ciudad de México, Mexico; Cátedras CONACyT - Instituto Nacional de Psiquiatría Ramón de la Fuente Muñiz, Ciudad de México, Mexico.Laboratorio de Neurofisiología Integrativa, Dirección de Investigaciones en Neurociencias. Instituto Nacional de Psiquiatría Ramón de la Fuente Muñiz, Ciudad de México, Mexico.Laboratorio de Fisiología Celular, Dirección de Investigaciones en Neurociencias. Instituto Nacional de Psiquiatría Ramón de la Fuente Muñiz, Ciudad de México, Mexico. Electronic address: fmercado@imp.edu.mx.

Pub Type(s)

Journal Article

Language

eng

PubMed ID

30876975

Citation

Mercado-Reyes, Jonathan, et al. "D2-like Receptor Agonist Synergizes the Μ-opioid Agonist Spinal Antinociception in Nociceptive, Inflammatory and Neuropathic Models of Pain in the Rat." European Journal of Pharmacology, vol. 853, 2019, pp. 56-64.
Mercado-Reyes J, Almanza A, Segura-Chama P, et al. D2-like receptor agonist synergizes the μ-opioid agonist spinal antinociception in nociceptive, inflammatory and neuropathic models of pain in the rat. Eur J Pharmacol. 2019;853:56-64.
Mercado-Reyes, J., Almanza, A., Segura-Chama, P., Pellicer, F., & Mercado, F. (2019). D2-like receptor agonist synergizes the μ-opioid agonist spinal antinociception in nociceptive, inflammatory and neuropathic models of pain in the rat. European Journal of Pharmacology, 853, 56-64. https://doi.org/10.1016/j.ejphar.2019.03.020
Mercado-Reyes J, et al. D2-like Receptor Agonist Synergizes the Μ-opioid Agonist Spinal Antinociception in Nociceptive, Inflammatory and Neuropathic Models of Pain in the Rat. Eur J Pharmacol. 2019 Jun 15;853:56-64. PubMed PMID: 30876975.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - D2-like receptor agonist synergizes the μ-opioid agonist spinal antinociception in nociceptive, inflammatory and neuropathic models of pain in the rat. AU - Mercado-Reyes,Jonathan, AU - Almanza,Angélica, AU - Segura-Chama,Pedro, AU - Pellicer,Francisco, AU - Mercado,Francisco, Y1 - 2019/03/13/ PY - 2018/10/04/received PY - 2019/02/25/revised PY - 2019/03/12/accepted PY - 2019/3/17/pubmed PY - 2019/9/10/medline PY - 2019/3/17/entrez KW - Analgesia KW - D2-like receptors KW - Dopamine KW - Modulation KW - Neuropathic pain KW - Opioid receptors SP - 56 EP - 64 JF - European journal of pharmacology JO - Eur J Pharmacol VL - 853 N2 - Opioids are potent analgesic drugs, but their use has been limited due to their side effects. Antinociceptive effects of D2-like receptor agonists such as quinpirole have been shown at the spinal cord level; however, their efficacy is not as high as that of opioids. Dopaminergic agonists are long-prescribed and well-tolerated drugs that have been useful to treat clinically and experimentally painful conditions. Because current pain treatments are not completely effective, the aim of this work was to determine if a D2-like receptor agonist improves the antinociceptive effects of a μ-opioid receptor agonist. Drugs were intrathecally administered in adult rats; mechanonociceptive and thermonociceptive tests were carried out. Intraplantar injection of complete Freund's adjuvant (CFA) and sciatic loose ligation (SLL) were used for inflammatory and neuropathic models of pain, respectively. In intact animals, D-Ala2, N-MePhe4, Gly-ol-enkephalin (DAMGO; a µ-opioid receptor agonist) increased the paw withdrawal latencies (PWL) in thermal and mechanical nociceptive tests in a dose-dependent manner. Quinpirole (D2-like receptor agonist) increased PWL only in mechanonociception. In the presence of quinpirole (1 nmol), the ED50 of the mechanical antinociceptive effect of DAMGO was significantly decreased (8-fold). Coadministration of 1 nmol quinpirole and 30 pmol DAMGO completely reversed hyperalgesia in the CFA model, whereas 100 pmol DAMGO plus 1 nmol quinpirole reversed the allodynia in the SLL model. This work offers evidence about a synergistic antinociceptive effect between opioidergic and dopaminergic drugs. This combination may relieve painful conditions resistant to conventional treatments, and it may reduce the adverse effects of chronic opioid administration. SN - 1879-0712 UR - https://www.unboundmedicine.com/medline/citation/30876975/D2_like_receptor_agonist_synergizes_the_μ_opioid_agonist_spinal_antinociception_in_nociceptive_inflammatory_and_neuropathic_models_of_pain_in_the_rat_ L2 - https://linkinghub.elsevier.com/retrieve/pii/S0014-2999(19)30175-X DB - PRIME DP - Unbound Medicine ER -